SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Free cash flow yield
Latest
-63.29%
↓ 33% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthCompressed
Average
-47.70%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -63.29% | +35.8% |
| 2024 | -98.65% | -48.0% |
| 2023 | -66.65% | +33.2% |
| 2022 | -99.82% | -3683.6% |
| 2021 | -2.64% | -326.9% |
| 2020 | -0.62% | +72.2% |
| 2019 | -2.23% | - |